Back
Ultragenyx Pharmaceutical Vs. Nike Industry Stock Comparison
Sell
46
RARE
Ultragenyx Pharmaceutical
Last Price:
56.57
Seasonality Move:
7.55%
Buy
58
NKE
Nike
Last Price:
89.17
Seasonality Move:
6.85%
Sell
46
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $56.56. The Score for RARE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Nike (NKE)
is a Buy
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $89.13. The Score for NKE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NKE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $56.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKE Stock Price Chart
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.6 | Buy |
| Relative Strength Index (14 RSI): | 53.19 | Buy |
| Chaikin Money Flow: | 285053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.65 - 58.23) | Sell |
| Bollinger Bands (100): | (40.36 - 54.44) | Buy |
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.41 | Buy |
| Relative Strength Index (14 RSI): | 71.81 | Buy |
| Chaikin Money Flow: | 6402088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.37 - 86.93) | Buy |
| Bollinger Bands (100): | (75.21 - 92.25) | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.53 | Buy |
| 20-day SMA: | 56.94 | Sell |
| 50-day SMA: | 53.49 | Buy |
| 200-day SMA: | 47 | Buy |
| 8-day EMA: | 56.35 | Buy |
| 20-day EMA: | 56.39 | Buy |
| 50-day EMA: | 53.6 | Buy |
| 200-day EMA: | 47.49 | Buy |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.07 | Buy |
| 20-day SMA: | 83.14 | Buy |
| 50-day SMA: | 80.06 | Buy |
| 200-day SMA: | 92.2 | Sell |
| 8-day EMA: | 87.44 | Buy |
| 20-day EMA: | 84.69 | Buy |
| 50-day EMA: | 82.67 | Buy |
| 200-day EMA: | 90.03 | Sell |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.62 per share.
Ultragenyx Pharmaceutical Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nike Technical Analysis
| Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||